Sort
172,184 grants matching “inflammation”
Ubiquitination, Intestinal Homeostasis and Cancer
$897,306Averil I Ma · University Of California, San Francisco · R01 · FY2025 · CA
The Use of Photobiomodulation (PBM) in the Treatment for Diabetic Macular Edema
$897,302Clark E Tedford · Lumithera, Inc. · R44 · FY2020 · EY
Inflammation and Insulin Resistance in PAD
$897,272Mark A Creager · Brigham And Women'S Hospital · R01 · FY2007 · HL
Novel Determinants for Progression of Non-Alcoholic Fatty Liver Disease to Hepatocellular Carcinoma and Other Health Outcomes
$897,025Jian-Min Yuan · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Evaluation of anti-fibrotic and anti-inflammatory semi-synthetic oxysterol, Oxy210, as a therapeutic drug candidate for non-alcoholic steatohepatitis
$896,990Farhad Parhami · Max Biopharma, Inc. · R44 · FY2023 · DK
The Black American United Memory & Aging Project (BA-UMAP): An examination of cognitive decline in midlife and older Black adults using remote cognitive assessments, risk factors & biomarkers
$896,914Travonia S Brown-Hughes · North Carolina Agri & Tech St Univ · R01 · FY2024 · AG
Obesity, related comorbidities, and breast cancer outcomes in African Americans
$896,846Elisa V Bandera · Rbhs -Cancer Institute Of New Jersey · R01 · FY2014 · CA
Analysis of cancer-related immune suppressor mechanisms in mice
$896,773Tim Greten · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
AZD9688: A First in Class Disease Modifying Therapy to Treat Alpha-1 Antitrypsin Deficiency a Genetically Linked Orphan Disease
$896,654Mark T Dransfield · University Of Alabama At Birmingham · UH3 · FY2021 · TR
Computer Integrated Systems for Microscopy&Manipulation
$896,520Richard Superfine · Univ Of North Carolina Chapel Hill · P41 · FY2007 · EB
A preclinical multi-modal system for dynamic noninvasive assessment of liver disease
$896,265Tomasz Joseph Czernuszewicz · Sonovol, Inc. · R44 · FY2018 · DK
Effects of Cannabidiol and Tetrahydrocannabinol on the Microbiome, Endocannabinoids and Neuroinflammation in HIV
$896,116Ronald J. Ellis · University Of California, San Diego · R01 · FY2024 · DA
Effects of Cannabidiol and Tetrahydrocannabinol on the Microbiome, Endocannabinoids and Neuroinflammation in HIV
$896,116Ronald J. Ellis · University Of California, San Diego · R01 · FY2023 · DA
Effects of Cannabidiol and Tetrahydrocannabinol on the Microbiome, Endocannabinoids and Neuroinflammation in HIV
$896,116Ronald J. Ellis · University Of California, San Diego · R01 · FY2022 · DA
Effects of Cannabidiol and Tetrahydrocannabinol on the Microbiome, Endocannabinoids and Neuroinflammation in HIV
$896,116Ronald J. Ellis · University Of California, San Diego · R01 · FY2025 · DA
Preventing Anthracycline Cardiovascular Toxicity with Statins
$896,071William Gregory Hundley · Wake Forest University Health Sciences · R01 · FY2017 · HL
Amelioration of Vesicant-Induced Skin Injury by High Dose 25-Hydroxyvitamin D
$896,035Kurt Lu · Case Western Reserve University · U01 · FY2016 · AR
Development of a transgenic rat to study brain aging
$895,834Inflame Therapeutics, Inc. · R42 · FY2005 · AG
Neurodifferentiation/Stem Cell Unit
$895,783David Wang · National Institute Of Neurological Disorders And Stroke · ZIC · FY2023 · NS
A Novel Immunological Probiotic for Treating Inflammatory Bowel Disease
$895,539Gary Fanger · Rise Therapeutics, Llc · R44 · FY2021 · DK
Phase 1 Safety, Pharmacokinetic study followed by Phase 2a Proof-of-Concept study of AVR-48, a small molecule macrophage modulator to prevent bronchopulmonary dysplasia in neonates
$895,365Suchismita Acharya · Ayuvis Research, Inc. · R44 · FY2024 · HD
Overall: Resource-based Center for Musculoskeletal Disorders Research (Overall Application)
$895,284Louis J. Soslowsky · University Of Pennsylvania · P30 · FY2024 · AR
Overall: Resource-based Center for Musculoskeletal Disorders Research (Overall Application)
$895,284Louis J. Soslowsky · University Of Pennsylvania · P30 · FY2023 · AR
Mechanisms by which red blood cells contribute cardiopulmonary bypass associated inflammation
$895,205Vishal Nigam · Seattle Children'S Hospital · R01 · FY2024 · HL
The Epidemiology of Home Allergens and Asthma
$895,189Diane R Gold · Brigham And Women'S Hospital · R01 · FY2009 · AI